Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
Improved three-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.